Patents by Inventor Alejandro Caicedo

Alejandro Caicedo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230072595
    Abstract: This invention provides in one aspect compositions that improve the corrosion-resistance of cementitious materials. In certain embodiments, the compositions of the invention inhibit the growth of acidophilic bacteria thriving in/on cementitious material.
    Type: Application
    Filed: January 21, 2021
    Publication date: March 9, 2023
    Inventors: Mark T. Hernandez, Ismael Justo Reinoso, Alejandro Caicedo-Ramirez
  • Publication number: 20200061121
    Abstract: The present invention provides novel drug discovery platforms and methods for treating diabetes.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 27, 2020
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Patent number: 10493108
    Abstract: The present invention provides novel drug discovery platforms and methods for treating diabetes.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: December 3, 2019
    Assignee: BioCrine AB
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Publication number: 20190070316
    Abstract: The present invention provides novel drug discovery platforms and methods for treating diabetes.
    Type: Application
    Filed: November 6, 2018
    Publication date: March 7, 2019
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Patent number: 10207012
    Abstract: The present invention provides novel drug discovery platforms and methods for treating type I diabetes.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: February 19, 2019
    Assignee: Biocrine AB
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Publication number: 20170035793
    Abstract: Pharmaceutical compositions containing P2X purinergic agonists, e.g. P2X3 agonists, for increasing insulin secretion in a subject, methods of use, and methods of screening for related compounds and agents.
    Type: Application
    Filed: October 7, 2016
    Publication date: February 9, 2017
    Inventors: Per-Olof BERGGREN, Alejandro CAICEDO, Caroline M. JACQUES-SILVA
  • Publication number: 20170000907
    Abstract: The present invention provides novel drug discovery platforms and methods for treating type I diabetes.
    Type: Application
    Filed: September 14, 2016
    Publication date: January 5, 2017
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Patent number: 9463205
    Abstract: The present invention provides novel drug discovery platforms and methods for treating type I diabetes.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: October 11, 2016
    Assignee: BioCrine AB
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Publication number: 20150105436
    Abstract: Methods for regulating glucagon release and of treating hypoglycemia, and for screening drug candidates for heating hypoglycemia. The methods are useful for treating diabetes melititus and screening drug candidates for potential efficacy.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 16, 2015
    Inventors: Per-Olof Berggren, Alejandro Caicedo, Over Cabrera
  • Publication number: 20150064144
    Abstract: The present invention provides novel drug discovery platforms and methods for treating type I diabetes.
    Type: Application
    Filed: October 15, 2014
    Publication date: March 5, 2015
    Inventors: Per-Olof Berggren, Alejandro Caicedo
  • Publication number: 20130217738
    Abstract: Methods for regulating glucagon release and of treating hypoglycemia, and for screening drug candidates for treating hypoglycemia. The methods are useful for treating diabetes mellitus and screening drug candidates for potential efficacy.
    Type: Application
    Filed: March 19, 2013
    Publication date: August 22, 2013
    Inventors: Per-Olof Berggren, Alejandro Caicedo, Over Cabrera
  • Patent number: 8466185
    Abstract: Methods for regulating glucagon release and of treating hypoglycemia, and for screening drug candidates for treating hypoglycemia. The methods are useful for treating diabetes mellitus and screening drug candidates for potential efficacy.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: June 18, 2013
    Assignee: BioCrine AB
    Inventors: Per-Olof Berggren, Alejandro Caicedo, Over Cabrera
  • Publication number: 20130053338
    Abstract: Pharmaceutical compositions containing P2X purinergic agonists, e.g. P2X3 agonists, for increasing insulin secretion in a subject, methods of use, and methods of screening for related compounds and agents.
    Type: Application
    Filed: March 21, 2011
    Publication date: February 28, 2013
    Inventors: Per-Olof Berggren, Alejandro Caicedo, Caroline M. Jacques-Silva
  • Publication number: 20110021584
    Abstract: Methods for regulating glucagon release and of treating hypoglycemia, and for screening drug candidates for treating hypoglycemia. The methods are useful for treating diabetes mellitus and screening drug candidates for potential efficacy.
    Type: Application
    Filed: March 12, 2009
    Publication date: January 27, 2011
    Applicant: University of Miami
    Inventors: Per-Olof Berggren, Alejandro Caicedo, Over Cabrera
  • Publication number: 20090060843
    Abstract: The present invention provides novel drug discovery platforms and methods for treating type I diabetes.
    Type: Application
    Filed: August 27, 2008
    Publication date: March 5, 2009
    Applicant: BIOCRINE AB
    Inventors: Per-Olof Berggren, Alejandro Caicedo